Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

Radiolabeled metaiodobenzylguanidine (mIBG) is a highly sensitive and specific marker for detecting neuroblastoma. A semiquantitative mIBG score (Curie score [CS]) was assessed for utility as a prognostic indicator for a cohort of patients with highrisk metastatic disease. METHODS: mIBG scans from 2...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Nucl Med
Autores principales: Yanik, Gregory A., Parisi, Marguerite T., Shulkin, Barry L., Naranjo, Arlene, Kreissman, Susan G., London, Wendy B., Villablanca, Judith G., Maris, John M., Park, Julie R., Cohn, Susan L., McGrady, Patrick, Matthay, Katherine K.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5503147/
https://ncbi.nlm.nih.gov/pubmed/23440556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.112.112334
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares